A. Abbott, Linked ecologies: States and universities as environments for professions, Sociological theory, vol.23, issue.3, pp.245-274, 2005.

M. Ansaloni and A. Smith, Une agence au service d'une stratégie ministérielle. La crise du Mediator et la concordance des champs, Gouvernement et action publique, vol.7, pp.33-55, 2017.

P. Aspers, Knowledge and valuation in markets, Theory and society, vol.38, issue.2, pp.111-131, 2009.

J. Beckert and C. Musselin, Constructing quality: The classification of goods in markets, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01392957

, The worth of goods: Valuation and pricing in the economy, 2011.

J. Beckert, The social order of markets, Theory and society, vol.38, pp.245-269, 2009.

H. Bergeron, P. Castel, S. Dubuisson-quellier, E. Nouguez, and O. Pilmis, Governing by labels? Not that simple: The cases of environmental and nutritional politics in France, Labelling the Economy. Qualities and values in contemporary markets, pp.185-206, 2020.
URL : https://hal.archives-ouvertes.fr/hal-02496702

H. Bergeron, P. Castel, H. Coutant, and E. Nouguez, Monitoring Drug Markets: From Biomedical to Social Valuation. The Case of French Medicines Agency, 2019.

H. Bergeron and P. Castel, Les habits neufs du néo-institutionnalisme? La redécouverte de l'ordre mésologique et de l'agency, L'Année sociologique, vol.66, issue.1, pp.31-72, 2016.

H. Bergeron and E. Nouguez, Les frontières de l'interdit: le commerce de cannabis, Marchés contestés: quand le marché rencontre la morale, 2015.

H. Bergeron, P. Castel, P. , and E. Nouguez, Towards a Sociology of the Boundary-Entrepreneur, Revue française de sociologie, vol.54, pp.263-302, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01719501

L. Boltanski and A. Esquerre, Enrichissement. Une critique de la marchandise, 2017.

L. Boltanski and L. Thévenot, On justification: Economies of worth, vol.27, 2006.

P. Bourdieu, Les structures sociales de l'économie, 2000.

G. C. Bowker and S. L. Star, Sorting things out: Classification and its consequences, 2000.

D. Carpenter, Reputation and power: organizational image and pharmaceutical regulation at the FDA, vol.137, 2014.

S. Carof and E. Nouguez, At the boundaries of food and medicine: the genesis and transformation of the "functional food" markets in France and Europe, LIEPP Working Paper, vol.90, pp.1-21, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02290956

P. Chauvin, Architecture des prix et morphologie sociale du marché, Revue française de sociologie, vol.52, pp.277-309, 2011.

F. Cochoy and S. Dubuisson-quellier, The sociology of market work, Economic Sociology_the European Electronic Newsletter, vol.15, issue.1, pp.4-11, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01522875

B. Coriat, The political economy of HIV/AIDS in developing countries: TRIPS, public health systems and free access, 2008.

J. Dewey, International encyclopedia of unified science 2, 4, vii + 67, 1939.

L. Doganova, Que vaut une molécule? Formulation de la valeur dans les projets de développement de nouveaux médicaments, Revue d'anthropologie des connaissances, vol.9, pp.17-38, 2015.

F. Dobbin, Forging industrial policy: The United States, Britain, and France in the railway age, 1994.

S. Dubuisson-quellier, Gouverner les conduites. Paris: Presses de Sciences Po, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01354197

I. Dussauge, C. F. Helgesson, and F. Lee, Value practices in the life sciences and medicine, 2015.

W. N. Espeland and M. L. Stevens, Commensuration as a social process, Annual review of sociology, vol.24, issue.1, pp.313-343, 1998.

D. Fassin, Les figures urbaines de la santé publique enquêtes sur des expériences locales, 1998.

N. Fligstein, The architecture of markets: An economic sociology of twenty-first-century capitalist societies, 2002.

E. Friedberg, Le pouvoir et la règle. Dynamiques de l'action organisée, 1993.

X. Frohlich, The Rise (and Fall) of the Food-Drug Line: Classification, Gatekeepers, and Spatial Mediation in Regulating U.S. Food and Health Markets, Risk on the Table: Food, Health, and Environmental Exposure, 2020.

T. F. Gieryn, Boundary-work and the demarcation of science from non-science: Strains and interests in professional ideologies of scientists, American sociological review, vol.48, pp.781-795, 1983.

J. A. Greene, Generic: The unbranding of modern medicine, 2014.

J. A. Greene, Prescribing by numbers: drugs and the definition of disease, 2006.

B. Hauray, L'Europe du médicament: politique-expertise-intérêts privés, Presses de Sciences Po, 2005.

C. F. Helgesson and F. Muniesa, For what it's worth: An introduction to valuation studies, Valuation Studies, vol.1, issue.1, pp.1-10, 2013.

L. Karpik, The economics of singularities, 2010.

M. Lounsbury and P. M. Hirsch, Markets on trial: The economic sociology of the US financial crisis, 2010.

G. Majone, The new European agencies: regulation by information, Journal of European Public Policy, vol.4, issue.2, pp.262-275, 1997.

M. Montalban and M. E. Sakinç, Financialization and productive models in the pharmaceutical industry, Industrial and Corporate Change, vol.22, issue.4, pp.981-1030, 2013.
URL : https://hal.archives-ouvertes.fr/hal-02425108

F. Muniesa, A flank movement in the understanding of valuation, The Sociological Review, vol.59, pp.24-38, 2011.
URL : https://hal.archives-ouvertes.fr/halshs-00706766

E. Nouguez, Des médicaments à tout prix: sociologie des génériques en France, Presses de Sciences Po, 2017.

E. Nouguez and C. Benoît, Governing (through) Prices Determining the Price of Reimbursed Pharmaceuticals in France, Revue française de sociologie, vol.58, issue.3, pp.399-424, 2017.

E. Nouguez, Governing the market through prices: The state and controls on the price of medicines in France, Economic Sociology_the European Electronic Newsletter, vol.15, issue.2, pp.41-48, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01025154

M. Quet, Impostures pharmaceutiques: médicaments illicites et luttes pour l'accès à la santé, 2018.

D. Stark, The sense of dissonance: Accounts of worth in economic life, 2011.

E. Hoen, TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha, Chicago Journal of International Law, vol.3, issue.1, pp.27-46, 2002.

F. Vatin, Valuation as evaluating and valorizing, Valuation Studies, vol.1, issue.1, pp.31-50, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01154593

F. Vatin, Évaluer et valoriser: une sociologie économique de la mesure, 2009.

S. Vogler, A. Vitry, and Z. Bahar, Cancer drugs in 16 European countries, Australia, and New Zealand: a cross-country price comparison study, The Lancet Oncology, vol.17, issue.1, pp.39-47, 2016.

V. A. Zelizer, Economic lives: How culture shapes the economy, 2013.